{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:22:51Z","timestamp":1790036571064,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CIC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11033-020-05703-0","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T08:57:31Z","timestamp":1599728251000},"page":"6507-6516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of novel candidate genes by exome sequencing in Tunisian familial male breast cancer patients"],"prefix":"10.1007","volume":"47","author":[{"given":"Wala","family":"Ben Kridis-Rejeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorra","family":"Ben Ayed-Guerfali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihel","family":"Ammous-Boukhris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajdi","family":"Ayadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamseddine","family":"Kifagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slim","family":"Charfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Saguem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahia","family":"Sellami-Boudawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamel","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afef","family":"Khanfir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1319-0061","authenticated-orcid":false,"given":"Raja","family":"Mokdad-Gargouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"issue":"2","key":"5703_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-008-0053-y","volume":"115","author":"V Speirs","year":"2009","unstructured":"Speirs V, Shaaban AM (2009) The rising incidence of male breast cancer. Breast Cancer Res Treat 115(2):429\u2013430. https:\/\/doi.org\/10.1007\/s10549-008-0053-y","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5703_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics. CA: Cancer J Clin 70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA: Cancer J Clin"},{"issue":"6","key":"5703_CR3","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/annonc\/mdt025","volume":"24","author":"KJ Ruddy","year":"2013","unstructured":"Ruddy KJ, Winer EP (2013) Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol 24(6):1434\u20131443. https:\/\/doi.org\/10.1093\/annonc\/mdt025","journal-title":"Ann Oncol"},{"issue":"2","key":"5703_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.critrevonc.2009.04.003","volume":"73","author":"L Ottini","year":"2010","unstructured":"Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A (2010) Male breast cancer. Crit Rev Oncol\/Hematol 73(2):141\u2013155. https:\/\/doi.org\/10.1016\/j.critrevonc.2009.04.003","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"1","key":"5703_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/his.12862","volume":"68","author":"S Deb","year":"2016","unstructured":"Deb S, Lakhani SR, Ottini L, Fox SB (2016) The cancer genetics and pathology of male breast cancer. Histopathology 68(1):110\u2013118. https:\/\/doi.org\/10.1111\/his.12862","journal-title":"Histopathology"},{"key":"5703_CR6","doi-asserted-by":"publisher","first-page":"viii75","DOI":"10.1093\/annonc\/mdt316","volume":"8","author":"P Rizzolo","year":"2013","unstructured":"Rizzolo P, Silvestri V, Tommasi S, Pinto R, Danza K et al (2013) Male breast cancer: genetics, epigenetics, and ethical aspects. Ann Oncol 8:viii75\u2013viii82. https:\/\/doi.org\/10.1093\/annonc\/mdt316","journal-title":"Ann Oncol"},{"issue":"6","key":"5703_CR7","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/jco.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480\u20131490. https:\/\/doi.org\/10.1200\/jco.2002.20.6.1480","journal-title":"J Clin Oncol"},{"issue":"11","key":"5703_CR8","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/ijc.30927","volume":"141","author":"G Zheng","year":"2017","unstructured":"Zheng G, Yu H, Hemminki A, F\u00f6rsti A, Sundquist K, Hemminki K (2017) Familial associations of female breast cancer with other cancers. Int J Cancer 141(11):2253\u20132259. https:\/\/doi.org\/10.1002\/ijc.30927","journal-title":"Int J Cancer"},{"issue":"2","key":"5703_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-008-0162-7","volume":"116","author":"M Wasielewski","year":"2009","unstructured":"Wasielewski M, den Bakker MA, van den Ouweland A, Meijer-van Gelder ME, Portengen H, Klijn JG (1100delC) CHEK2 1100delC and male breast cancer in the Netherlands. Breast Cancer Res Treat 116(2):397\u2013400. https:\/\/doi.org\/10.1007\/s10549-008-0162-7","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5703_CR10","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s12885-017-3631-8","volume":"17","author":"S Hallamies","year":"2017","unstructured":"Hallamies S, Pelttari LM, Poikonen-Saksela P, Jekunen A et al (2017) CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population. BMC Cancer 17(1):620. https:\/\/doi.org\/10.1186\/s12885-017-3631-8","journal-title":"BMC Cancer"},{"issue":"2","key":"5703_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/cncr.30337","volume":"123","author":"V Silvestri","year":"2017","unstructured":"Silvestri V, Zelli V, Valentini V, Rizzolo P, Navazio AS et al (2017) Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene. Cancer 123(2):210\u2013218. https:\/\/doi.org\/10.1002\/cncr.30337","journal-title":"Cancer"},{"issue":"3","key":"5703_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10549-019-05429-z","volume":"178","author":"R Scarpitta","year":"2019","unstructured":"Scarpitta R, Zanna I, Aretini P, Gambino G, Scatena C et al (2019) Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing. Breast Cancer Res Treat 178(3):557\u2013564. https:\/\/doi.org\/10.1007\/s10549-019-05429-z","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5703_CR13","first-page":"169","volume":"12","author":"N Missaoui","year":"2011","unstructured":"Missaoui N, Jaidene L, Abdelkrim SB, Abdelkader AB, Beizig N et al (2011) Breast cancer in Tunisia: clinical and pathological findings. Asian Pac J Cancer Prev 12(1):169\u2013172","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"5703_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ijc.32106","volume":"145","author":"P Rizzolo","year":"2019","unstructured":"Rizzolo P, Zelli V, Silvestri V, Valentini V, Zanna I et al (2019) Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy. Int J Cancer 145(2):390\u2013400. https:\/\/doi.org\/10.1002\/ijc.32106","journal-title":"Int J Cancer"},{"issue":"3","key":"5703_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10549-016-4085-4","volume":"161","author":"M Pritzlaff","year":"2017","unstructured":"Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P et al (2017) Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat 161(3):575\u2013586. https:\/\/doi.org\/10.1007\/s10549-016-4085-4","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5703_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12282-016-0693-4","volume":"24","author":"A Riahi","year":"2017","unstructured":"Riahi A, El Ghourabi M, Fourati A, Chaabouni-Bouhamed H (2017) Family history predictors of BRCA1\/BRCA2 mutation status among Tunisian breast\/ovarian cancer families. Breast Cancer 24(2):238\u2013244. https:\/\/doi.org\/10.1007\/s12282-016-0693-4","journal-title":"Breast Cancer"},{"key":"5703_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cca.2007.10.018","volume":"388","author":"K Chahed","year":"2008","unstructured":"Chahed K, Kabbage M, Hamrita B, Guillier CL, Trimeche M et al (2008) Detection of protein alterations in male breast cancer using two-dimensional gel electrophoresis and mass spectrometry: the involvement of several pathways in tumorigenesis. Clin Chim Acta 388:106\u2013114. https:\/\/doi.org\/10.1016\/j.cca.2007.10.018","journal-title":"Clin Chim Acta"},{"issue":"3","key":"5703_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/BD-170315","volume":"37","author":"S Abdeljaoued","year":"2018","unstructured":"Abdeljaoued S, Bettaieb L, Nasri M, Adouni O, Goucha A et al (2018) Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer. Breast Dis 37(3):109\u2013114","journal-title":"Breast Dis"},{"issue":"4","key":"5703_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3233\/cbm-190637","volume":"26","author":"M Manai","year":"2019","unstructured":"Manai M, Abdeljaoued S, Goucha A, Adouni O, Bettaieb I et al (2019) MARCKS protein overexpression is associated with poor prognosis in male breast cancer. Cancer Biomark 26(4):513\u2013522. https:\/\/doi.org\/10.3233\/cbm-190637","journal-title":"Cancer Biomark"},{"key":"5703_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.breast.2017.12.013","volume":"38","author":"V Silvestri","year":"2018","unstructured":"Silvestri V, Rizzolo P, Zelli V, Valentini V, Zanna I et al (2018) A possible role of FANCM mutations in male breast cancer susceptibility: results from a multicenter study in Italy. Breast 38:92\u201397. https:\/\/doi.org\/10.1016\/j.breast.2017.12.013","journal-title":"Breast"},{"issue":"3","key":"5703_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-018-05096-6","volume":"174","author":"AR Bowden","year":"2019","unstructured":"Bowden AR, Tischkowitz M (2019) Clinical implications of germline mutations in breast cancer genes: RECQL. Breast Cancer Res Treat 174(3):553\u2013560. https:\/\/doi.org\/10.1007\/s10549-018-05096-6","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5703_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12881-018-0524-x","volume":"19","author":"T Nguyen-Dumont","year":"2018","unstructured":"Nguyen-Dumont T, Myszka A, Karpinski P, Sasiadek MM, Akopyan H et al (2018) FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine. BMC Med Genet 19(1):12. https:\/\/doi.org\/10.1186\/s12881-018-0524-x","journal-title":"BMC Med Genet"},{"issue":"1","key":"5703_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10549-018-4661-x","volume":"169","author":"F Fostira","year":"2018","unstructured":"Fostira F, Saloustros E, Apostolou P, Vagena A, Kalfakakou D et al (2018) Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer. Breast Cancer Res Treat 169(1):105\u2013113. https:\/\/doi.org\/10.1007\/s10549-018-4661-x","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"5703_CR24","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303","journal-title":"Genome Res"},{"issue":"2","key":"5703_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","volume":"18","author":"NT Doncheva","year":"2019","unstructured":"Doncheva NT, Morris JH, Gorodkin J, Jensen LJ (2019) Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res 18(2):623\u2013632. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00702","journal-title":"J Proteome Res"},{"issue":"3","key":"5703_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.14670\/hh-27.377","volume":"27","author":"S Karray-Chouayekh","year":"2012","unstructured":"Karray-Chouayekh S, Trifa F, Khabir A, Sellami-Boudawara T, Frikha M et al (2012) Negative\/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma. Histol Histopathol 27(3):377\u2013385. https:\/\/doi.org\/10.14670\/hh-27.377","journal-title":"Histol Histopathol"},{"issue":"Suppl 1","key":"5703_CR27","doi-asserted-by":"publisher","first-page":"I7","DOI":"10.1093\/annonc\/mdh651","volume":"15","author":"G Cipollini","year":"2004","unstructured":"Cipollini G, Tommasi S, Paradiso A, Aretini P, Bonatti F et al (2004) Genetic alterations in hereditary breast cancer. Ann Oncol 15(Suppl 1):I7\u2013i13. https:\/\/doi.org\/10.1093\/annonc\/mdh651","journal-title":"Ann Oncol"},{"issue":"1","key":"5703_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12967-018-1504-9","volume":"16","author":"Y Hamdi","year":"2018","unstructured":"Hamdi Y, Boujemaa M, Ben Rekaya M, Ben Hamda C, Mighri N et al (2018) Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases. J Trans Med 16(1):158. https:\/\/doi.org\/10.1186\/s12967-018-1504-9","journal-title":"J Trans Med"},{"issue":"12","key":"5703_CR29","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/ijc.31273","volume":"142","author":"A Riahi","year":"2018","unstructured":"Riahi A, Radmanesh H, Schurmann P, Bogdanova N, Geffers R et al (2018) Exome sequencing and case-control analyses identify RCC1 as a candidate breast cancer susceptibility gene. Int J Cancer 142(12):2512\u20132517. https:\/\/doi.org\/10.1002\/ijc.31273","journal-title":"Int J Cancer"},{"key":"5703_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ceb.2014.01.005","volume":"27","author":"M O\u2019Hayre","year":"2014","unstructured":"O\u2019Hayre M, Degese MS, Gutkind JS (2014) Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr Opt Cell Biol 27:126\u2013135. https:\/\/doi.org\/10.1016\/j.ceb.2014.01.005","journal-title":"Curr Opt Cell Biol"},{"key":"5703_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellsig.2017.09.005","volume":"41","author":"A Nieto Gutierrez","year":"2018","unstructured":"Nieto Gutierrez A, McDonald PH (2018) GPCRs: Emerging anti-cancer drug targets. Cell Signal 41:65\u201374. https:\/\/doi.org\/10.1016\/j.cellsig.2017.09.005","journal-title":"Cell Signal"},{"issue":"9","key":"5703_CR32","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.18632\/oncotarget.3049","volume":"6","author":"J Liu","year":"2015","unstructured":"Liu J, Han P, Li M, Yan W, Liu J et al (2015) The histidine-rich calcium binding protein (HRC) promotes tumor metastasis in hepatocellular carcinoma and is upregulated by SATB1. Oncotarget 6(9):6811\u20136824. https:\/\/doi.org\/10.18632\/oncotarget.3049","journal-title":"Oncotarget"},{"issue":"1","key":"5703_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/labinvest.3700699","volume":"88","author":"SL Butler","year":"2008","unstructured":"Butler SL, Dong H, Cardona D, Jia M, Zheng R et al (2008) The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab Invest 88(1):78\u201388. https:\/\/doi.org\/10.1038\/labinvest.3700699","journal-title":"Lab Invest"},{"issue":"2","key":"5703_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajpath.2010.10.023","volume":"178","author":"H Liu","year":"2011","unstructured":"Liu H, Dong H, Robertson K, Liu C (2011) DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma. Am Pathol 178(2):652\u2013661. https:\/\/doi.org\/10.1016\/j.ajpath.2010.10.023","journal-title":"Am Pathol"},{"issue":"11","key":"5703_CR35","doi-asserted-by":"publisher","first-page":"11097","DOI":"10.1007\/s13277-014-2425-8","volume":"35","author":"YY Lee","year":"2014","unstructured":"Lee YY, Li CF, Lin CY, Chen G, Lee SW et al (2014) Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy. Tumour Biol 35(11):11097\u201311105. https:\/\/doi.org\/10.1007\/s13277-014-2425-8","journal-title":"Tumour Biol"},{"issue":"2","key":"5703_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00006676-200208000-00003","volume":"25","author":"T Sato","year":"2002","unstructured":"Sato T, Kashima K, Gamachi A, Daa T, Nakayama I et al (2002) Immunohistochemical localization of pyruvate carboxylase and carbamyl-phosphate synthetase I in normal and neoplastic human pancreatic tissues. Pancreas 25(2):130\u2013135. https:\/\/doi.org\/10.1097\/00006676-200208000-00003","journal-title":"Pancreas"},{"issue":"2","key":"5703_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1389202911314020002","volume":"14","author":"N Clark","year":"2013","unstructured":"Clark N, Wu X, Her C (2013) MutS homologues hMSH4 and hMSH5: genetic variations, functions, and implications in human diseases. Curr Genomics 14(2):81\u201390. https:\/\/doi.org\/10.2174\/1389202911314020002","journal-title":"Curr Genomics"},{"issue":"3","key":"5703_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41388-019-1001-5","volume":"39","author":"N Kiavue","year":"2020","unstructured":"Kiavue N, Cabel L, Melaabi S, Bataillon G, Callens C et al (2020) ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics. Oncogene 39(3):487\u2013502. https:\/\/doi.org\/10.1038\/s41388-019-1001-5","journal-title":"Oncogene"},{"issue":"45","key":"5703_CR39","doi-asserted-by":"publisher","first-page":"27773","DOI":"10.18632\/oncotarget.25576","volume":"9","author":"R Mishra","year":"2018","unstructured":"Mishra R, Alanazi S, Yuan L, Solomon T, Thaker TM et al (2018) Activating HER3 mutations in breast cancer. Oncotarget 9(45):27773\u201327788. https:\/\/doi.org\/10.18632\/oncotarget.25576","journal-title":"Oncotarget"},{"issue":"2","key":"5703_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bbamcr.2009.07.006","volume":"1803","author":"F Bartolini","year":"2010","unstructured":"Bartolini F, Gundersen GG (2010) Formins and microtubules. Biochem Biophys Acta 1803(2):164\u2013173. https:\/\/doi.org\/10.1016\/j.bbamcr.2009.07.006","journal-title":"Biochem Biophys Acta"},{"issue":"7","key":"5703_CR41","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1158\/0008-5472.can-08-3709","volume":"69","author":"F Liz\u00e1rraga","year":"2009","unstructured":"Liz\u00e1rraga F, Poincloux R, Romao M, Montagnac G, Le Dez G et al (2009) Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells. Cancer Res 69(7):2792\u20132800. https:\/\/doi.org\/10.1158\/0008-5472.can-08-3709","journal-title":"Cancer Res"},{"issue":"1","key":"5703_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ijgo.12997","volume":"148","author":"S Verma","year":"2020","unstructured":"Verma S, Bakshi D, Sharma V, Sharma I, Shah R et al (2020) Genetic variants of DNAH11 and LRFN2 genes and their association with ovarian and breast cancer. Int J Gynaecol Obstet 148(1):118\u2013122. https:\/\/doi.org\/10.1002\/ijgo.12997","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"5703_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13058-018-1020-0","volume":"20","author":"AA Leontovich","year":"2018","unstructured":"Leontovich AA, Jalalirad M, Salisbury JL, Mills L, Haddox C et al (2018) NOTCH3 expression is linked to breast cancer seeding and distant metastasis. Breast Cancer Res 20(1):105. https:\/\/doi.org\/10.1186\/s13058-018-1020-0","journal-title":"Breast Cancer Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05703-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05703-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05703-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:09:32Z","timestamp":1631059772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05703-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5703"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05703-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"18 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consents were obtained from all participants. Ethical approval according to the Declaration of Helsinki Principles was obtained from the biomedical ethics committee of University Hospital Habib Bourguiba of Sfax -Tunisia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients included in the study. This study is approved by Ethic committee of University Hospitals of Sfax-Tunisia.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}